Work

Liver transplantation in primary sclerosing cholangitis: timing, changing indications, results, and complications

Year: 2023
Type: dissertation
Study design: Observational Study
Abstract: Background. Primary sclerosing cholangitis (PSC) is a chronic cholestatic disease. Patients with PSC are at high risk of developing cholangiocarcinoma (CCA). The only curative treatment for PSC is liver transplantation (LTx), however, CCA is considered a contraindication. In 2001, our center started liver transplantations for patients with dysplasia in endoscopic retrograde cholangiography (ERC) brush cytology samples. These patients were considered to be at increased risk of developing CCA. This thesis compares LTx results in two groups of PSC patients with different indications. Patients and Methods. This thesis includes all 199 consecutive PSC patients transplanted in the Helsinki University Hospital between 1984 and 2020. They were divided into two LTx indication groups, either symptomatic end-stage liver disease (n=151, classical indication) or suspicious findings in ERC brush samples (n=48, premalignant indication). Brush sample cytology and cytometry were compared with final histopathological findings of the explanted liver (I). Health-related quality of life (HRQoL) between the two indications were compared before and after transplantation (II). The 15D questionnaire was used to measure HRQoL. Histological findings in protocol graft biopsies of PSC were compared with another autoimmune disease, primary biliary cholangitis (PBC) (III). Complications after LTx were studied between the two PSC patient indications (IV). Comprehensive complication index (CCI®) was calculated and analyzed between the two indications. Data for the studies were collected from electronic patients records and the Finnish Liver Transplantation Registry. Results. Brush sample cytology and cytometry were compared with the histology of explanted liver in 101 patients: 66 patients with classical indication and 35 with premalignant indication. Cytology without flow cytometry was suspicious in 9 patients (14%) with classical indication and in 17 patients (49%) from the premalignant group. When the cytology findings were combined with flow cytometry, they were found to have 68% sensitivity and 86% specificity for malignant explanted liver histology. Ten-year survival was 91% in the premalignant group. HRQoL results were from 48 PSC patients both pre-LTx and post-LTx (II). The premalignant group included 16 and the classical group 32 patients. HRQoL remained high after LTx in the premalignant group and was almost at the level of the age- and gender-standardized general population. Protocol biopsies presented frequent histopathological findings in the grafts despite normal biochemistry (III). More than one abnormal histopathological finding was in 43% of PSC patients and in 62% of PBC patients. However, PBC patients had a longer follow-up. Immunosuppression was reduced based on protocol biopsy in 10% of patients and increased in 6% of patients. Findings leading to increase immunosuppression included significantly more portal, endothelial, interphase, and lobular inflammation. All consecutive PSC patients (n=199) transplanted by the end of 2020 were included in the study to analyze one-year post-transplant and overall complications (IV). No significant differences emerged between the two PSC groups in one-year CCI® or overall CCI®. Long-term overall survival was similar in both groups. The only factor with statistical significance for survival was one-year CCI® over 42, which predicted lower overall survival. Five- and 10-year survivals were 90% and 82% for premalignant indication and 88% and 86% for classical indication, respectively. Conclusions. Dysplasia surveillance with brush cytology may help to find patients at risk of developing CCA and to optimize the timing of liver transplantation. However, it is possible that some transplanted patient’s dysplasia would never have progressed to malignancy. Protocol biopsies are useful to safely reduce immunosuppression. LTx results are similar for premalignant and classical indication and complication rates are low after LTx. Long-term survival after LTx is excellent, however, whether overall survival improves in the premalignant group is unknown.
Language: English
Subfield: Hepatology
Field: Medicine
Open Access status: green
OpenAlex ID: W7198601946
Cites:
Cited by: 1
Related to: 10